IPRIPR2025-00233Institution Denied
Formycon AGv.Regeneron Pharmaceuticals, Inc.
IPR challenge of US 11084865.
Type
IPR
Filed
Dec 2, 2024
Instituted
Jun 2, 2025
Decided
Jun 2, 2025
Patent
Application
16739559
Inventor
Eric FURFINE et al
Granted
Aug 10, 2021
01
Timeline
3 milestones
2024-12-02Petition filed
2025-06-02Institution
2025-06-02Terminated
02
Parties & counsel
Petitioner
Formycon AG
Counsel
Fogel, Louiset al
Patent Owner
Regeneron Pharmaceuticals, Inc.
Counsel
Berl, Davidet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →